Anebulo Pharmaceuticals, Inc. SEC filings ANEB
Anebulo Pharmaceuticals, Inc. has 204 filings in SEC EDGAR's recent list, going back to Jun 25, 2020. Its latest annual report, Form 10-K, was filed on Sep 29, 2025 for the period ended Jun 30, 2025. The latest quarterly report (Form 10-Q) was filed on Feb 12, 2026, covering the quarter ended Dec 31, 2025. The most recent current report (Form 8-K) was filed on Feb 12, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Jul 23, 2025 | Jul 23, 2025 |
| DEF 14A | Proxy statement | Mar 6, 2025 | Mar 6, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 24, 2025 | Feb 24, 2025 |
| DEF 14A | Proxy statement | Oct 30, 2023 | Oct 30, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 19, 2023 | Oct 19, 2023 |
| DEF 14A | Proxy statement | Oct 17, 2022 | Oct 17, 2022 |
| DEFA14A | Additional proxy material | Sep 22, 2021 | — |
| DEF 14A | Proxy statement | Sep 22, 2021 | Sep 22, 2021 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANEB (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Lakeway, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1815974
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.